National Bank of Canada
TEVA icon

National Bank of Canada’s Teva Pharmaceuticals TEVA Stock Holding History

National Bank of Canada’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.56M Sell
282,227
-190,445
-40% -$6.34M 0.01% 756
2026
Q1 		$14.2M Sell
472,672
-450,241
-49% -$14.5M 0.01% 591
2025
Q4 		$28.8M Buy
922,913
+728,603
+375% +$17.9M 0.03% 432
2025
Q3 		$3.93M Buy
194,310
+179,229
+1,188% +$3.15M ﹤0.01% 929
2025
Q2 		$252K Sell
15,081
-692
-4% -$11.2K ﹤0.01% 1557
2025
Q1 		$242K Sell
15,773
-1,003,753
-98% -$17.9M ﹤0.01% 1484
2024
Q4 		$22.5M Buy
1,019,526
+1,001,230
+5,472% +$18.2M 0.02% 533
2024
Q3 		$330K Sell
18,296
-1,259
-6% -$22K ﹤0.01% 1284
2024
Q2 		$319K Sell
19,555
-363
-2% -$5.59K ﹤0.01% 1248
2024
Q1 		$324K Sell
19,918
-16,483
-45% -$208K ﹤0.01% 1321
2023
Q4 		$388K Buy
36,401
+615
+2% +$5.74K ﹤0.01% 1308
2023
Q3 		$356K Sell
35,786
-18,225
-34% -$170K ﹤0.01% 1399
2023
Q2 		$406K Buy
54,011
+16,865
+45% +$137K ﹤0.01% 1331
2023
Q1 		$329K Sell
37,146
-31,521
-46% -$312K ﹤0.01% 1297
2022
Q4 		$626K Sell
68,667
-33,531
-33% -$293K ﹤0.01% 1215
2022
Q3 		$815K Sell
102,198
-1,907,924
-95% -$16.9M ﹤0.01% 1042
2022
Q2 		$15.1M Buy
2,010,122
+1,900,596
+1,735% +$16.6M 0.07% 302
2022
Q1 		$1.02M Buy
109,526
+1,392
+1% +$11.6K ﹤0.01% 1103
2021
Q4 		$834K Buy
+108,134
New +$976K ﹤0.01% 1110

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

National Bank of Canada's TEVA Position: Q2 2026 in Review

National Bank of Canada reduced its Teva Pharmaceuticals (TEVA) stake by 40% in Q2 2026, selling an estimated $6.34M and leaving 282,227 shares worth $9.56M. The position accounts for 0.01% of the portfolio, ranked #756.

National Bank of Canada first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $28.8M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • National Bank of Canada held 282,227 shares of Teva Pharmaceuticals worth $9.56M as of Q2 2026.
  • National Bank of Canada sold 190,445 Teva Pharmaceuticals shares in Q2 2026, an estimated $6.34M.
  • Teva Pharmaceuticals made up 0.01% of National Bank of Canada's portfolio in Q2 2026, its #756 holding.
  • National Bank of Canada first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Teva Pharmaceuticals position peaked at $28.8M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.